These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26464624)
41. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
42. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression. Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381 [TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
44. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825 [TBL] [Abstract][Full Text] [Related]
45. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142 [TBL] [Abstract][Full Text] [Related]
46. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. Yeung BH; Shek FH; Lee NP; Wong CK PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082 [TBL] [Abstract][Full Text] [Related]
47. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150 [TBL] [Abstract][Full Text] [Related]
48. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling. Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763 [TBL] [Abstract][Full Text] [Related]
49. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer. Hunecke D; Spanel R; Länger F; Nam SW; Borlak J J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869 [TBL] [Abstract][Full Text] [Related]
50. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737 [TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807 [TBL] [Abstract][Full Text] [Related]
52. Circadian disruption accelerates liver carcinogenesis in mice. Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225 [TBL] [Abstract][Full Text] [Related]
53. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma]. Shen L; Qui D; Fang J Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889 [TBL] [Abstract][Full Text] [Related]
54. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine. Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673 [TBL] [Abstract][Full Text] [Related]
55. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model. Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170 [TBL] [Abstract][Full Text] [Related]
56. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras. Zhang QL; Tian DA; Xu XJ Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851 [TBL] [Abstract][Full Text] [Related]
57. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949 [TBL] [Abstract][Full Text] [Related]
58. The biology of IQGAP proteins: beyond the cytoskeleton. Hedman AC; Smith JM; Sacks DB EMBO Rep; 2015 Apr; 16(4):427-46. PubMed ID: 25722290 [TBL] [Abstract][Full Text] [Related]
59. Animal models as a tool in hepatocellular carcinoma research: A Review. Santos NP; Colaço AA; Oliveira PA Tumour Biol; 2017 Mar; 39(3):1010428317695923. PubMed ID: 28347231 [TBL] [Abstract][Full Text] [Related]
60. Watch the GAP: Emerging Roles for IQ Motif-Containing GTPase-Activating Proteins IQGAPs in Hepatocellular Carcinoma. Schmidt VA Int J Hepatol; 2012; 2012():958673. PubMed ID: 22973521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]